Lumos Pharma, Inc. (LUMO) Posts FY21 Loss of $3.65/Share

Lumos Pharma, Inc. (NASDAQ: LUMO) reported FY21 EPS of $(3.65), versus ($0.93) last year. Revenue for the year came in at $230K, versus $168K reported last year.

For earnings history and earnings-related data on Lumos Pharma, Inc. (LUMO) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Exyn Technologies, Inc. (EXYN) Reports Q2 Loss of $1.55
• Ocean Power Technologies revises fiscal 2026 results after audit